TP53 and cancer: Gene set enrichment analysis (GSEA) revealed that, compared with other types of cancer cells, SLCs presented significant enrichment of MYC targets and WNT-β-catenin pathway genes but inhibited the cell cycle G2M checkpoint and p53 pathway (Fig. 3f).